Compare
Cresco Labs Inc. vs Ascend Wellness Holdings, Inc. vs USANA Health Sciences Inc vs Trulieve Cannabis Corp.
| Latest fiscal year | Cresco Labs Inc. CRLBF | Ascend Wellness Holdings, Inc. AAWH | USANA Health Sciences Inc USNA | Trulieve Cannabis Corp. TRLV |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-01-03 | 2025-12-31 |
| Revenue | $655.85M | $500.58M | $925.26M | $1.18B |
| Revenue growth (YoY) | -9.5% | -10.9% | +8.3% | -0.4% |
| Gross margin | 49.5% | 33.9% | 78.3% | 60.2% |
| Operating margin | -4.3% | -3.4% | 4.0% | 12.1% |
| Net margin | -20.6% | -23.6% | 1.2% | -10.3% |
| Net income | -$135.41M | -$118.19M | $10.76M | -$122.25M |
| EPS (Diluted) | -$0.38 | -$0.58 | $0.58 | -$0.58 |
| Operating cash flow | $72.89M | $38.05M | $22.35M | $272.82M |
| Free cash flow | $37.75M | $12.04M | $8.53M | $228.63M |
| Cash & equivalents | $57.90M | $85.68M | $158.38M | $255.53M |
| Total assets | $1.20B | $907.93M | $742.91M | $2.70B |
| Total liabilities | $944.80M | $954.55M | $156.64M | $1.55B |
| Shareholders' equity | $340.45M | -$46.62M | $533.10M | $1.14B |
| Return on year-end equity | -39.8% | n/a | 2.0% | -10.7% |
| Shares outstanding | n/a | 202.22M | 18.28M | 192.31M |
Revenue, most recent five fiscal years
| Fiscal year | Cresco Labs Inc. | Ascend Wellness Holdings, Inc. | USANA Health Sciences Inc | Trulieve Cannabis Corp. |
|---|---|---|---|---|
| Latest | $655.85M Ended 2025-12-31 | $500.58M Ended 2025-12-31 | $925.26M Ended 2026-01-03 | $1.18B Ended 2025-12-31 |
| 1 year earlier | $724.34M Ended 2024-12-31 | $561.60M Ended 2024-12-31 | $854.50M Ended 2024-12-28 | $1.19B Ended 2024-12-31 |
| 2 years earlier | $770.88M Ended 2023-12-31 | $518.59M Ended 2023-12-31 | $921.01M Ended 2023-12-30 | $1.13B Ended 2023-12-31 |
| 3 years earlier | n/a | $405.93M Ended 2022-12-31 | $998.60M Ended 2022-12-31 | $1.22B Ended 2022-12-31 |
| 4 years earlier | n/a | $332.38M Ended 2021-12-31 | $1.19B Ended 2022-01-01 | $931.93M Ended 2021-12-31 |